Brief: Advaxis And Personalis Announce Agreement To Deploy Immunoid Next Platform
11/02/2020 13:30
Feb 11 (Reuters) - Advaxis Inc ADXS.O :
* ADVAXIS AND PERSONALIS ANNOUNCE RESEARCH AGREEMENT TO
DEPLOY
IMMUNOID NEXT PLATFORM IN THE ADXS-503 CLINICAL PROGRAM
Source text for Eikon: ID:nGNXc10qcz
Further company coverage: ADXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors